These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23570222)

  • 1. [Issues in cancer pharmacogenomics].
    Korean J Hepatol; 2005; 11 Suppl 1():19-31. PubMed ID: 23570222
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics: from bedside to clinical practice.
    Marsh S; McLeod HL
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer pharmacogenetics.
    Marsh S
    Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.
    Ansari M; Krajinovic M
    Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer pharmacogenetics: polymorphisms, pathways and beyond.
    Ulrich CM; Robien K; McLeod HL
    Nat Rev Cancer; 2003 Dec; 3(12):912-20. PubMed ID: 14740638
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
    Krynetski E; Evans WE
    Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR; McLeod HL
    J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer pharmacogenomics: progress and obstacles toward the goal.
    Nishiyama M
    Int J Clin Oncol; 2005 Feb; 10(1):3-4. PubMed ID: 15729593
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenetics of cytotoxic drugs.
    Daly AK; Hall AG
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and pharmacogenomics: a clinical reality.
    Ferraldeschi R; Newman WG
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):410-7. PubMed ID: 21733927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacogenetics and pharmacogenomics of cancers].
    Robert J
    Pathol Biol (Paris); 2004 Jul; 52(6):332-7. PubMed ID: 15261376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer pharmacogenomics: do cancer cell lines have the right stuff?
    Auman JT
    Pharmacogenomics; 2010 Aug; 11(8):1035-7. PubMed ID: 20712522
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomic applications in clinical drug development.
    Dracopoli NC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S57-60. PubMed ID: 12856151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.